|
CTNM Contineum Therapeutics Inc 1855175 |
| Balance Sheet |
|
Current Assets
|
215,143,000 |
|
Assets
|
216,034,000 |
|
Current Liabilities
|
5,806,000 |
|
Liabilities
|
5,806,000 |
|
Equity
|
210,228,000 |
|
Shares Out
|
18,994,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-22,643,000 |
|
Investing Cash Flow
|
-60,351,000 |
| Market Analysis |
Market Cap
|
421,861,618 |
|
Price
|
12.44 |
|
BVPS
|
11.07 |
|
PB
|
1.13 |
|
EPS
|
-1.24 |
|
PS
|
3.56 |
|
FCF
|
-82,994,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CTNM documents filed with the SEC.
CTNM Filings
Clear
